Low dose naltrexone for induction of remission in Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 15 tweeters
wikipedia: 1 Wikipedia page

video: 1 video uploader

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 162 Mendeley

Summary Twitter Wikipedia Video Dimensions citations

So far, Dimensions has found 21 publications that cite this research output.

21

The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.

Mild Crohn’s Disease: Definition and Management

Article in Current Colorectal Cancer Reports (February 2023)

Low-dose naltrexone for treatment of burning mouth syndrome

Article in Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (April 2022)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study

Article in BMJ Open (April 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.